Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
Obesity is a complex disease and leading cause of morbidity and mortality and there are only insufficient treatment options available…
Pharmaceuticals, Biotechnology and Life Sciences
Obesity is a complex disease and leading cause of morbidity and mortality and there are only insufficient treatment options available…
Allergan and Gedeon Richter got the U.S. Food and Drug Administration approval for a supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine) for expanded use to treat depressive episodes associated with bipolar I disorder (bipolar depression) in adults.
Ansun Biopharma has welcomed the first patient to its Phase 3 clinical trial to test DAS181 a recombinant sialidase protein that can cleave sialic acid, the virus receptors located on the surface of epithelial cells lining the human respiratory track.
Schreiner MediPharm developed the Patch-Safe specialty label for PS Marketing & Outsourcing GmbH, to be used for safe disposal of patches containing active ingredients.
Preclinical study supports Vor’s approach for empowering targeted
immunotherapies through hematopoietic stem cell editing
Paper co-authored by Vor co-founder Dr. Siddhartha Mukherjee
Teva presents 17 posters and three oral presentations at EHF 2019 highlighting long-term and FOCUS Phase IIIb study data The…
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specialises in the development of…
Sustained, clinically meaningful bilateral improvement in visual functions 96 weeks after injection Observed bilateral improvement interpreted as clearly superior to…
Technology produces novel heavy chain-only antibodies for bi-specific, single domain antibodies or CAR-Ts CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands, &…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) announced today that Scott Tarriff, Chief Executive Officer,…